Stryker Corporation $SYK Position Increased by Nichols & Pratt Advisers LLP MA

Nichols & Pratt Advisers LLP MA boosted its position in shares of Stryker Corporation (NYSE:SYK) by 7.3% in the second quarter, Holdings Channel.com reports. The firm owned 57,022 shares of the medical technology company’s stock after purchasing an additional 3,856 shares during the period. Stryker comprises 1.1% of Nichols & Pratt Advisers LLP MA’s holdings, making the stock its 27th largest holding. Nichols & Pratt Advisers LLP MA’s holdings in Stryker were worth $17,953,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Stryker during the 4th quarter worth about $1,822,272,000. Bank of America Corp DE bought a new stake in shares of Stryker in the 2nd quarter valued at approximately $1,404,284,000. Auto Owners Insurance Co increased its holdings in Stryker by 35,047.0% in the fourth quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock worth $1,024,444,000 after buying an additional 2,906,448 shares during the last quarter. Legal & General Group Plc acquired a new position in Stryker in the second quarter worth approximately $707,212,000. Finally, Jupiter Topco LLC bought a new position in Stryker during the second quarter valued at approximately $681,581,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SYK has been the subject of several recent research reports. Wolfe Research downgraded shares of Stryker from an “outperform” rating to a “peer perform” rating in a research report on Thursday, August 13th. JPMorgan Chase & Co. lowered their target price on shares of Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Friday, July 31st. Evercore set a $350.00 target price on Stryker in a report on Monday, July 6th. Barclays reduced their price target on Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. Finally, Citizens Jmp lowered their price objective on Stryker from $440.00 to $400.00 and set a “market outperform” rating on the stock in a report on Monday, August 3rd. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Stryker has an average rating of “Moderate Buy” and an average target price of $386.28.

Stryker Stock Performance

Shares of SYK opened at $331.32 on Friday. The company has a market capitalization of $127.08 billion, a PE ratio of 34.33, a price-to-earnings-growth ratio of 2.11 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. Stryker Corporation has a one year low of $281.00 and a one year high of $396.86. The company’s fifty day moving average price is $329.10 and its 200 day moving average price is $331.47.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.49 by $0.20. The company had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm’s revenue was up 9.4% compared to the same quarter last year. During the same period last year, the business posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, analysts expect that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is 36.48%.

Insiders Place Their Bets

In other news, insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the transaction, the insider directly owned 6,210 shares in the company, valued at $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Dylan Bram Crotty sold 441 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the sale, the insider owned 6,102 shares in the company, valued at approximately $2,005,178.22. The trade was a 6.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 351,267 shares of company stock valued at $118,197,701 in the last three months. Company insiders own 4.60% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.